Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Zensar Technologies Merger & Restructuring

Zensar Technologies announced the completed merger of its US subsidiaries M3BI LLC and Bridgeview Life Sciences LLC into Zensar Technologies Inc. The mergers become effective September 1, 2026.

Key figures
Execution periodEffective September 1, 2026
Source

BSE filing, NSE: ZENSARTECH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Zensar Technologies Ltd: key numbers

Share price
₹565.75
Market cap
₹12,875 Cr
Revenue (annual)
₹5,687 Cr
Net profit (annual)
₹774.6 Cr
P/E (TTM)
16.4×Sector 23.8×
Promoter holding
48.98%-0.01% QoQ
FII holding
10.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zensar Technologies Ltd

All →

Other merger & restructuring announcements

All →